Duration of Hydrocortisone Effect
The plasma elimination half-life of hydrocortisone is approximately 90 minutes, with demonstrable effects evident within one hour after IV administration and persisting for a variable period, though excretion is nearly complete within 12 hours. 1, 2
Pharmacokinetic Parameters by Route of Administration
Intravenous Administration
- Elimination half-life: Approximately 90 minutes (range 40-225 minutes with significant inter-individual variation) 1, 3
- Onset of action: Effects evident within 1 hour 2
- Duration of effect: Variable, but excretion nearly complete within 12 hours 2
- Dosing frequency required: Every 4-6 hours if constantly high blood levels are needed 2
- Total body clearance: 18 L/hr with volume of distribution of 34 L 4
Important caveat: The half-life may be shorter in patients taking CYP3A4 inducers or those with hyperthyroidism, and longer in critically ill patients (cortisol clearance reduced by >50% during critical illness) 1, 5
Oral Administration
- Bioavailability: Excellent at 94-96% 1, 6, 4
- Time to peak concentration (Tmax): 60-70 minutes (range 20-118 minutes) 6, 3
- Peak plasma levels: Achieved at approximately 1-1.2 hours after administration 6
- Duration until undetectable levels:
- Time to cortisol <100 nmol/L: Approximately 289 minutes (range 140-540 minutes), significantly influenced by both absorption rate and half-life 3
Clinical implication: The short half-life of oral hydrocortisone necessitates 2-3 times daily dosing to maintain adequate coverage 7, 8
Intramuscular/Subcutaneous Administration
- Pharmacokinetics: Similar to IV administration when given IM 2
- Subcutaneous absorption: Slower than IM (time to reach cortisol 1000 nmol/L: 22 minutes SC vs 11 minutes IM) but still clinically effective 5
- Duration: Excretion pattern similar to IV injection 2
Therapeutic Duration in Stress Situations
Surgical/Perioperative Context
- Plasma cortisol normalization: Returns to baseline within 24-48 hours after uncomplicated major surgery 1
- Recommended coverage duration:
Acute Illness/Adrenal Crisis
- High-dose therapy duration: Should be continued only until patient stabilizes, usually not beyond 48-72 hours 2
- Maintenance after crisis: Triple normal oral dose for several days with progressive reduction 9
Factors Affecting Duration
Individual variability is substantial and influenced by: 1, 3
- CYP3A4 enzyme inducers (shorter half-life)
- Thyroid status (hyperthyroidism shortens half-life)
- Critical illness (prolongs half-life and reduces clearance by >50%)
- Obesity (may require higher doses)
- Time of day (evening bioavailability may be 128% vs 94% in morning, reflecting decreased clearance) 6
Practical Dosing Implications
For continuous therapeutic effect:
- IV hydrocortisone requires dosing every 4-6 hours for sustained high blood levels 2
- Oral hydrocortisone requires 2-3 times daily administration due to 1.5-hour half-life 7
- Continuous IV infusion (200 mg/24h) is superior to intermittent dosing for maintaining physiologic stress response levels 1
Common pitfall: Assuming uniform duration across all patients—the range of half-life (40-225 minutes) and time to subtherapeutic levels (140-540 minutes) demonstrates marked inter-individual variation requiring individualized monitoring 3